Clinical Trial Update: GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MajesTEC-5 in multiple myeloma, currently recruiting at University of Heidelberg Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: University of Heidelberg Medical Center | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING